BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7006846)

  • 21. Intraportal chemotherapy in colorectal carcinoma as an adjuvant modality.
    Metzger U; Mermillod B; Aeberhard P; Gloor F; Bissat A; Egeli R; Laffer U; Martinoli S; Mueller W; Schroeder R
    World J Surg; 1987 Aug; 11(4):452-8. PubMed ID: 3114965
    [No Abstract]   [Full Text] [Related]  

  • 22. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical management of advanced gastrointestinal cancer.
    Moertel CG
    Cancer; 1975 Aug; 36(2):675-82. PubMed ID: 168961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).
    Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
    Cancer; 1979 Sep; 44(3):858-63. PubMed ID: 476597
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of metastatic colorectal cancer with hepatic artery combination chemotherapy.
    Cohen AM; Schaeffer N; Higgins J
    Cancer; 1986 Mar; 57(6):1115-7. PubMed ID: 3080221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
    Kane RC; Cashdollar MR; Bernath AM
    Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
    Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
    Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized trial of melphalan plus 5-fluorouracil (5-FU) versus methyl-CCNU plus 5-FU in patients with advanced colorectal cancer.
    Berman R; Giles GR; Malhotra A; Bird GG; Gajjar PD; Bunch GA; Hall R
    Cancer Treat Rep; 1978 Mar; 62(3):457-9. PubMed ID: 348316
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
    Belt RJ; Stephens R
    Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematological toxicity of adjuvant portal liver infusion with fluorouracil, mitomycin and heparin.
    Weber W; Metzger U; Laffer U; Egeli R
    Anticancer Res; 1991; 11(1):365-8. PubMed ID: 1902076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non resectable colonic cancer. Results from a test of chemotherapy with simultaneous prescription of VM26, methyl-CCNU and 5 fluoro-uracile (author's transl)].
    Pouillart P; Palangie T; Jouve M; Langlois A; Garcia-Giralt E; Regensberg C; Blic V; Huguenin P; Morin P; Gautier H; Baron A; Dat-Xuong
    Nouv Presse Med; 1978 Jun; 7(25):2235-8. PubMed ID: 673790
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of hepatic artery infusion with 5-fluorouracil, adriamycin, and mitomycin C (FAM) in liver metastases from colorectal carcinoma.
    Wils J; Schlangen J; Naus A
    Cancer Chemother Pharmacol; 1984; 13(3):215-7. PubMed ID: 6548420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
    Joss RA; Goldberg RS; Yates JW
    Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An aggressive, sequential combination chemotherapy regimen in the treatment of metastatic colorectal carcinoma.
    Beck TM; Hart NE; Woodard DA; Smith CE
    Prog Clin Biol Res; 1986; 216():399-405. PubMed ID: 3088599
    [No Abstract]   [Full Text] [Related]  

  • 35. Nitrosoureas: useful agents for the treatment of advanced gastrointestinal cancer.
    Douglass HO; Lavin PT; Moertel CG
    Cancer Treat Rep; 1976 Jun; 60(6):769-80. PubMed ID: 782699
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of dacarbazine, mitomycin C, 5-fluorouracil and vincristine in advanced colorectal cancer.
    Falkson G; Pretorius HL; Falkson HC; Schoeman HS
    Cancer Chemother Pharmacol; 1983; 11(3):203-4. PubMed ID: 6416696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyl-CCNU versus methyl-CCNU and 5-fluorouracil in carcinoma of the large bowel.
    Posey LE; Morgan LR
    Cancer Treat Rep; 1977 Nov; 61(8):1453-8. PubMed ID: 922750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.